By: Elissa Tam, PharmD Candidate c/o 2015 - Patients with Type 1 or Type 2 diabetes who cannot control their…
By: Anthony Botte and Tyler Valente, PharmD Candidates c/o 2016 - Diseases which are prevalent within the pediatric population require…
By: Bharat Kirthivasan, Co-Copy Editor (Content-focused) - It’s graduation season and some students are moving from academics to professional life.…
By: Davidta Brown, Senior Staff Editor - In 21st century medicine, pharmaceuticals have come to include compounds derived through novel…
By: Elizabeth Kopec, PharmD Candidate c/o 2014, South University School of Pharmacy at Columbia, SC - Human immunodeficiency virus (HIV)…
By: Sang Hyo Kim, Staff Editor - Near the end of December, the pharmaceutical company, MannKind Corp, will submit their…
By: Nathan Trustman, PharmD Candidate c/o 2014, AMSCOP at LIU - The antibiotic class known as the fluoroquinolones is widely…
By: Sang Hyo Kim, Staff Editor - On March 29th 2013, the U.S Food and Drug Administration approved canagliflozin (Invokana®),…
By: Miriam Maltz, PharmD Candidate c/o 2013, AMSCOP, Long Island University - Type 2 diabetes mellitus (T2DM) is a metabolic…
By: Eugene Kolomiyets, PharmD Candidate c/o 2013, AMSCOP at LIU - Cystic fibrosis (CF) is an autosomal recessive disease caused…
By: Mohamed Dungersi, Associate Student Editor - What is diabetic ketoacidosis (DKA)? Diabetic ketoacidosis (DKA) is an acute complication of…
By: Lila Ahmed, Pharm.D. Candidate c/o 2013 - Whether you wish to admit it or not, all of us have…
By: Jena Marion, Pharm.D. Candidate c/o 2013 - I have traveled a lot these past few years. I have packed…
By: Shannon Tellier - Medication related problems can be reduced in older adults if the Beers Criteria were utilized by…
By: Lunbao (Jerry) Huang, Pharm.D. Candidate c/o 2013 - Counterfeit prescription medications are becoming a great concern for us. They…
By: Ebey P. Soman - The FDA recently approved a combination tablet of linagliptin with metformin hydrochloride (Jentadueto®) for the…
By: Mohamed Dungersi - On January 27, the FDA approved Bydureon® (exenatide extended-release) for use in Type 2 Diabetes Mellitus…